Home
Search Abstracts
Browse Sessions
Program Committee
Conference Webcasts
Contact Us
Session 142
Poster Abstracts
Renal and Bone Abnormalities
Thursday, 1:30 - 3:30 pm
Hall B
818
Chronic Kidney Disease and the Use of HAART
Ronald Reisler*
1
, L Jacobson
2
, S Gupta
3
, W Qiao
2
, J Margolick
2
, S Riddler
4
, B Visscher
5
, C Williams
6
, and F Palella
7
1
Inst of Human Virology, Univ of Maryland, Baltimore, USA;
2
Johns Hopkins Univ, Bloomberg Sch of Publ Hlth, Baltimore, MD, USA;
3
Indiana Univ Sch of Med, Indianapolis, USA;
4
Univ of Pittsburgh Grad Sch of Publ Hlth, PA, USA;
5
Univ of California, Los Angeles, Sch of Publ Hlth, USA;
6
DAIDS, NIAID, NIH, DHHS, Bethesda, MD, USA; and
7
Northwestern Univ, Feinberg Sch of Med, Chicago, IL, USA
819
Beyond Serum Creatinine: Identification of Renal Insufficiency Using Gglomerular Filtration: Implications for Clinical Research and Care
Stephen Becker*
1
, R Balu
2
, and J Fusco
2
1
Pacific Horizon Med Group, San Francisco, CA, USA and
2
GlaxoSmithKline, Research Triangle Park, NC, USA
820
Decline in Renal Function Associated with Tenofovir DF Compared with Nucleoside Reverse Transcriptase Inhibitor Treatment
Joel Gallant*, M Parish, J Keruly, and R Moore
Johns Hopkins Univ Sch of Med, Baltimore, MD, USA
821
HIV is Associated with Increased Prevalence of Microalbuminuria
L Szczech
1
, Carl Grunfeld*
2,5
, J Canchola
3
, S Sydney
4
, and M Shlipak
2,5
1
Duke Univ Med Ctr, Durham, NC, USA;
2
Univ of California, San Francisco, USA;
3
Univ of California, San Francisco, USA;
4
Kaiser Northern California Div of Res, Oakland, USA; and
5
San Francisco VA Med Ctr, CA, USA
822
Pathophysiologic Correlates of RANKL Deregulation in HIV Infection and Its Therapy
Mohamad Fakruddin jamiluddin*
1
, M Yin
2
, and J Laurence
3
1
Weill Med Coll, Cornell Univ, New York, NY, USA;
2
Columbia Univ Mailman Sch of Publ Hlth, New York, NY, USA; and
3
Weill Med Coll, Cornell Univ, New York, NY, USA
823
Similar Incidence of Osteopenia and Osteoporosis in ART-naïve Patients Treated with Tenofovir DF or Stavudine in Combination with Lamivudine and Efavirenz over 144 Weeks
William Powderly*
1
, C Cohen
2
, J Gallant
3
, B Lu
4
, J Enejosa
4
, A Cheng
4
, and Study 903 Team
1
Univ Coll, Dublin, Ireland;
2
Community Res Initiative New England, Boston, MA, USA;
3
Johns Hopkins Univ Sch of Med, Baltimore, MD, USA; and
4
Gilead Sci, Foster City, CA, USA
824
Serum Cholesterol Concentrations as well as Fasting Glycemia Is Associated with Decreased Bone Mineral Density and High Osteoblastic Activity in HIV-1-infected Patients
A Wiercinska-Drapalo, Jerzy Jaroszewicz*, E Tarasow, and D Prokopowicz
Med Univ of Bialystok, Poland
825
Duration of ARTand Change in Bone Mineral Density over Time
Denise Jacobson*
1
, J Huang
1
, A Shevitz
1,2
, T Knox
1
, S Gorbach
1,2
, and D Spiegelman
3
1
Tufts Univ Sch of Med, Boston, MA, USA;
2
Tufts-New England Med Ctr, Boston, MA, USA; and
3
Harvard Sch of Publ Hlth, Boston, MA, USA